Table 1 Characteristics of the study participants classified by obesity status.
|  | All participants (n = 7259) | Obese participants (n = 2839) | Non-obese participants (n = 4420) | P-value |
|---|---|---|---|---|
Age (years) | 54 (48–60) | 54 (48–61) | 54 (48–60) | 0.051 |
Sex (male) | 4309 (59.4) | 2070 (72.9) | 2239 (50.7) | <0.001 |
Hypertension (yes) | 1462 (20.1) | 812 (28.6) | 650 (14.7) | <0.001 |
Diabetes (yes) | 402 (5.5) | 180 (6.3) | 222 (5.0) | 0.018 |
Dyslipidaemia (yes) | 586 (8.1) | 276 (9.7) | 310 (7.0) | <0.001 |
Current smoker (yes) | 1026 (19.8) | 453 (21.7) | 573 (18.5) | 0.005 |
Alcohol status (yes) | 3143 (43.3) | 1376 (66.0) | 1769 (56.8) | <0.001 |
BMI (kg/m2) | 24.1 (22.0–26.3) | 27.0 (25.9–28.8) | 22.5 (20.9–23.8) | <0.001 |
SBP (mmHg) | 125 (114–135) | 130 (120–139) | 121 (111–132) | <0.001 |
Fasting glucose (mg/dL) | 97 (90–106) | 100 (93–111) | 95 (88–103) | <0.001 |
eGFR (mL/min/1.73 m2) | 95 (84–103) | 94 (82–102) | 96 (85–104) | <0.001 |
LDL-cholesterol (mg/dL) | 128 (106–153) | 131 (108–158) | 126 (104–149) | <0.001 |
CRP (mg/L) | 0.7 (0.3–1.5) | 1.0 (0.5–2.0) | 0.5 (0.3–1.1) | <0.001 |
AST (IU/L) | 24 (20–30) | 26 (21–33) | 23 (19–29) | <0.001 |
ALT (IU/L) | 23 (16–32) | 28 (20–40) | 20 (15–28) | <0.001 |
γ-GT (IU/L) | 24 (16–39) | 31 (21–50) | 20 (14–31) | <0.001 |
NAFLD (yes) | 3328 (45.8) | 1974 (69.5) | 1354 (30.6) | <0.001 |
No steatosis | 3931 (54.2) | 864 (22.0) | 3066 (78.0) | Â |
Mild steatosis | 1604 (22.1) | 771 (48.1) | 833 (51.9) | Â |
Mild to moderate steatosis | 284 (3.9) | 164 (57.7) | 120 (42.3) | Â |
Moderate steatosis | 1054 (14.5) | 720 (68.3) | 334 (31.7) | Â |
Moderate to severe steatosis | 171 (2.4) | 131 (76.6) | 40 (23.4) | Â |
Severe steatosis | 215 (2.9) | 188 (87.4) | 27 (12.6) | Â |
Abdominal obesity (yes) | 4698 (64.6) | 2648 (93.3) | 2050 (46.4) | <0.001 |
CAC (yes) | 2231 (30.7) | 1087 (38.3) | 1144 (25.9) | <0.001 |